Management of patients with rising prostate-specific antigen after radical prostatectomy

被引:30
|
作者
Laufer, M
Pound, CR
Carducci, MA
Eisenberger, MA
机构
[1] Johns Hopkins Univ, Johns Hopkins Oncol Ctr, Sch Med, Baltimore, MD 21287 USA
[2] Tel Aviv Sourasky Med Ctr, Dept Urol, Tel Aviv, Israel
[3] Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, Baltimore, MD USA
关键词
D O I
10.1016/S0090-4295(99)00465-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:309 / 315
页数:7
相关论文
共 50 条
  • [31] BIOLOGICAL HALF-LIFE OF PROSTATE-SPECIFIC ANTIGEN AFTER RADICAL PROSTATECTOMY
    VANSTRAALEN, JP
    BOSSENS, MMF
    DEREIJKE, TM
    SANDERS, GTB
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1994, 32 (02): : 53 - 55
  • [32] Elimination of serum complexed prostate-specific antigen after radical retropubic prostatectomy
    Stephan, C
    Jung, K
    Brux, B
    Lein, M
    Sinha, P
    Schnorr, D
    Leoning, SA
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (04) : 309 - 311
  • [33] Complexed prostate-specific antigen for the diagnosis of biochemical recurrence after radical prostatectomy
    Parsons, J. Kellogg
    Partin, Alan W.
    Trock, Bruce
    Bruzek, Debra J.
    Cheli, Carol
    Sokoll, Lori J.
    BJU INTERNATIONAL, 2007, 99 (04) : 758 - 761
  • [34] INFLUENCE OF PROSTATE CANCER TUMOUR STAGE AND GRADE ON SERUM PROSTATE-SPECIFIC ANTIGEN IN PATIENTS AFTER RADICAL PROSTATECTOMY
    Smiltens, I
    Romula, I
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 535 - 535
  • [35] Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer
    Kupelian, P
    Katcher, J
    Levin, H
    Zippe, C
    Klein, E
    UROLOGY, 1996, 48 (02) : 249 - 260
  • [36] Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy
    Smith, MR
    Manola, J
    Kaufman, DS
    George, D
    Oh, WK
    Mueller, E
    Slovin, S
    Spiegelman, B
    Small, E
    Kantoff, PW
    CANCER, 2004, 101 (07) : 1569 - 1574
  • [37] Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy
    Mouraviev, Vladimir
    Sun, Leon
    Madden, John F.
    Mayes, Janice M.
    Moul, Judd W.
    Polascik, Thomas J.
    UROLOGY, 2007, 70 (06) : 1141 - 1145
  • [38] Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 183 (02): : 553 - 554
  • [39] DISTANT METASTASIS AFTER RADICAL PROSTATECTOMY IN PATIENTS WITHOUT AN ELEVATED SERUM PROSTATE-SPECIFIC ANTIGEN LEVEL
    LEIBMAN, BD
    DILLIOGLUGIL, O
    WHEELER, TM
    SCARDINO, PT
    CANCER, 1995, 76 (12) : 2530 - 2534
  • [40] Radical prostatectomy for prostate cancer patients with prostate-specific antigen >20 ng/ml
    Ou, YC
    Chen, JT
    Cheng, CL
    Ho, HC
    Yang, CR
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 574 - 579